ArticleMethods in molecular biology (Clifton, N.J.)2026
Antibody Affinity Maturation by Computational Design.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This chapter aims to provide the reader with an overview of how to leverage computational algorithms toward improving the affinity of an antibody for a particular target. In most cases, structural information is required; however, the prerequisite information is not always available. Here, we take a bottom-up approach that will guide readers through scenarios where data such as antibody apo or complex structures are unknown. The focus of the chapter is on how computational tools and workflows can be used to address these limitations when attempting to identify an affinity-matured antibody variant with desirable properties. We begin with an overview of antibody structure prediction, followed by predictions of antibody-antigen complexes, antibody affinity, stability, and developability. Finally, we conclude this chapter with guidance notes and best practices for antibody computational design.
Indexed as
Identifiers
42129086What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.